Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Other hematologic neoplasm 1Lymphoid 1Gastrointestinal 1

Conditions

Colorectal Neoplasms 442Rectal Neoplasms 209Colonic Neoplasms 202Pancreatic Neoplasms 133Stomach Neoplasms 117Neoplasm Metastasis 86Esophageal Neoplasms 57Carcinoma, Hepatocellular 41Adenocarcinoma Of Esophagus 37Neoplasms 36Cholangiocarcinoma 27Biliary Tract Neoplasms 23Gastrointestinal Neoplasms 20Gallbladder Neoplasms 20Adenocarcinoma 19Carcinoma, Non-Small-Cell Lung 16Esophageal Squamous Cell Carcinoma 15Liver Neoplasms 14Bile Duct Neoplasms 14Digestive System Neoplasms 9Parkinson Disease 4, Autosomal Dominant Lewy Body 8Colorectal Cancer Metastatic 8Appendiceal Neoplasms 7Peritoneal Neoplasms 6Ovarian Neoplasms 6Intestinal Neoplasms 6Carcinoma 6Breast Neoplasms 6Lung Neoplasms 5Carcinoma, Renal Cell 5

Interventions

Gemcitabine 3Docetaxel 3belinostat 2Fluorouracil 2Filgrastim 2venetoclax 1toripalimab 1spartalizumab 1resiquimod 1poly ICLC 1ivosidenib 1enasidenib 1durvalumab 1birinapant 1alanosine 1Topotecan 1Thiotepa 1Thalidomide 1Quality of Life 1Patient Reported Outcome Measures 1Nivolumab 1Molecular Diagnostic Techniques 1Metformin 1Medicare Part B 1Leucovorin 1Irinotecan 1Ipilimumab 1Immunotherapy 1IFL protocol 1HhAntag691 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Chondrosarcoma × Leucovorin × Gastrointestinal × Clear all
NCT04553692 2025-03-28

Phase 1a/1b Study of Aplitabart (IGM-8444) Alone or in Combination in Participants with Relapsed, Refractory, or Newly Diagnosed Cancers

IGM Biosciences, Inc.

Phase 1 Terminated
272 enrolled
GastrointestinalLymphoidOther hematologic neoplasmSarcoma

Chondrosarcoma, Lymphoma, Non-Hodgkin, Neoplasm Metastasis, Sarcoma, Colorectal Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡